statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation

Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR...

MannKind Repays Certain Debt Obligations

Credit and security agreement with MidCap Financial Trust repaid in full for approximately $31.6 millionConvertible note issued to Mann Group LLC repaid in exchange for 1.5 million shares of common...

MannKind management to meet with Oppenheimer

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Institutional investors may overlook MannKind Corporation's (NASDAQ:MNKD) recent US$105m market cap drop as long-term gains remain positive

Key Insights Given the large stake in the stock by institutions, MannKind's stock price might be vulnerable to their...

Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?

It has been about a month since the last earnings report for Iovance Biotherapeutics (IOVA). Shares have lost about 6.9% in that time frame, underperforming the S&P 500.Will the recent negative trend...

May 10th Options Now Available For MannKind (MNKD)

Investors in MannKind Corp (MNKD) saw new options begin trading today, for the May 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD options chain...

MannKind CFO Binder to retire, Christopher Prentiss named successor

MannKind Announces CFO Transition

Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through December 31, 2024Christopher Prentiss appointed Chief...

MannKind (MNKD, $4.9) entered Uptrend as Momentum indicator ascends above 0 level on Mar 25, 2024

This indicator may be signaling MNKD's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

MannKind (MNKD, $4.76) entered Downtrend as Momentum indicator drops below 0 level on Mar 21, 2024

This indicator may be signaling that MNKD's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Volume	1.96M
52-Wk High	$6.04
52-Wk Low	$3.17

MNKD Mannkind Corp

About

Feed

News

Sentiment

Earnings

Fundamentals